TWP
GILD icon

Triad Wealth Partners’s Gilead Sciences GILD Stock Holding History

Triad Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Buy
4,715
+1,003
+27% +$132K 0.04% 278
2026
Q1 		$517K Buy
3,712
+211
+6% +$29.5K 0.04% 271
2025
Q4 		$430K Buy
3,501
+1,192
+52% +$145K 0.04% 299
2025
Q3 		$256K Buy
2,309
+462
+25% +$52.5K 0.03% 318
2025
Q2 		$205K Buy
+1,847
New +$197K 0.04% 285
2024
Q3 		– Sell
-922
Closed -$63.3K – 374
2024
Q2 		$63.3K Buy
+922
New +$61.5K 0.03% 193

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Triad Wealth Partners's GILD Position: Q2 2026 in Review

Triad Wealth Partners increased its Gilead Sciences (GILD) stake by 27% in Q2 2026, buying an estimated $132K and bringing the position to 4,715 shares worth $618K. The position accounts for 0.04% of the portfolio, ranked #278.

Triad Wealth Partners first reported a position in GILD in Q2 2024 and has held it in 6 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triad Wealth Partners held 4,715 shares of Gilead Sciences worth $618K as of Q2 2026.
  • Triad Wealth Partners bought 1,003 Gilead Sciences shares in Q2 2026, an estimated $132K.
  • Gilead Sciences made up 0.04% of Triad Wealth Partners's portfolio in Q2 2026, its #278 holding.
  • Triad Wealth Partners first reported a position in Gilead Sciences in Q2 2024 and has held it in 6 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.